A source of information
that few know exists
Members get the change to define and prioritize the most pressing challenges we want to tackle, as well as influence how we tackle them. Among the critical challenges your peers want to address include:

Discussing the required clinical efficacy outcome for microbiome products vs classical therapeutics

Building investor confidence in microbiome drug development .

Navigating the unclear regulatory process for LBPs and harmonizing global regulatory affairs

Discovering translatability and consistency of pre-clinical models and how they adapt to microbiome products

Defining what a good model looks like whilst considering the risk and efficacy?

Ensuring what we’re developing has sufficient potency to have a clinically meaningful treatment effect to meet the regulatory endpoints

Understanding what the clinical endpoints of relevance are
The feedback from members speaks for itself…
For more reviews about Microbiome Drug Discovery: Searchlight membership, head to our testimonials page and hear directly from our members about why they've joined.
Membership brochure
For more information on what’s included as part of the Microbiome Drug Development: Searchlight membership, please download the membership brochure.
Here’s what you’ll learn more about:
- The unique mission and purpose of the network
- What membership includes
- How the quarterly cornerstone meetings work
- How bespoke value delivery works
- How we deliver demonstrable value to you
- Annual member investment